Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

Circulation

Volumn 101, Issue 9, 2000, Pages 948-954

  Suwaidi, Jassim Al ^a   Hamasaki, Shuichi ^a   Higano, Stuart T ^a   Nishimura, Rick A ^a   Holmes Jr , David R ^a   Lerman, Amir ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acetylcholine; Atherosclerosis; Coronary disease; Endothelium

Indexed keywords

ACETYLCHOLINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING;

EID: 0001654669     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.9.948     Document Type: Article

References (30)

1. Goode GK, Miller JE, Heagerty AM. Hyperlipidemia, hypertension, and coronary heart disease. Lancet. 1995;345:362-264.
2. Egashira K, Inou T, Yamada A, Hirooka Y, Marouka Y, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:91-37.
3. Vita JA, Traesure CB, Nable EG, Mclenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
4. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cordiol. 1994;23:833-843.
5. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation. 1993;88:77-81.
6. Treasure CB, Klein L, Vita JA, Manoukian SV. Renwick GH, Selwyn AP, Ganz P, Alexander W. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87:86-93.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
8. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 1997;30:325-333.
9. Zeiher AM, Drexeler H, Wollschlyger H, Just H. Modulation of coronary vascular tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83: 391-401.
10. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:3390-3395.
11. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced ischemia. Circulation. 1995;91: 2345-2352.
12. Brown BG, Zhao X, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into the prevention of plaque disruption and clinical events in coronary disease. Circulation. 1993;87:1781-1791.
13. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;18:565-574.
14. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
15. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461-1467.
16. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol. 1995;26:41-49.
17. Pinto FJ, St Goar FG, Fischell TA, Stadius ML, Valantine HA, Alderman EL, Popp RL. Nitroglycerin-induced coronary vasodilation in cardiac transplant recipients: evaluation with in vivo intracoronary ultrasound. Circulation. 1992;85:69-77.
18. Tobis JM, Mallery J, Mahon D, Lehmann K, Zalesky P, Griffith J, Gessert J, Moriuchi M, McRae M, Dwyer ML, Greep N, Henry WL. Intravascular ultrasound imaging of human coronary arteries in vivo: analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation. 1991;83:913-926.
19. Doucette JW, Corl PD, Payne HM. Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85:1899-1911.
20. Serruys PW, Di Mario C, Piek J, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Muhlberger V, Danzi G, Peels HO, Ford AJ. Boersma E. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary angioplasty: the DEBATE study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation. 1997;96:3369-3377.
21. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
22. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
23. Fish ED, Nable EG, Selwyn AP, Ludemer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988;81: 21-31.
24. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH. Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051.
25. Werns SW, Walton JA, Hsia HH, Nable EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation. 1989;79:787-791.
26. Cooke JP, Singer AH, Tsao PS, Zera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
27. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB. Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokineinduced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
28. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
29. Lerman A, Burnett JC, Higano ST, McKinley LJ, Holmes DR Jr. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation. 1998;97:2123-2128.
30. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842-1847.